Predictive factors of toxicity of immune checkpoint inhibitors (ICI) in older patients with lung cancer: The ToxImmune study.

被引：0
|
作者：
Helissey, Carole
Difoum, Francoise
Vanquaethem, Helene
Vuagnat, Perrine
Picchi, Hugo
Le Roy, Audrey
Schernberg, Antoine
机构：
[1] Mil Hosp Begin, Clin Res Unit, St Mande, France
[2] Mil Hosp Begin, St Mande, France
[3] Hop Instruct Armees Begin, St Mande, France
[4] Gustave Roussy, Drug Dev Dept DITEP, Villejuif, France
[5] Mil Hosp Begin, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12048
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prognostic factors of toxicity of immune checkpoint inhibitors in nonsmall cell lung cancer and small cell lung cancer patients: The ToxImmune study
    Difoum, Francoise
    Schernberg, Antoine
    Vanquaethem, Helene
    Picchi, Hugo
    Le Roy, Audrey
    Vuagnat, Perrine
    Helissey, Carole
    CANCER REPORTS, 2023, 6 (07)
  • [2] C-reactive protein (CRP) as a predictive biomarker in lung cancer patients receiving immune checkpoint inhibitors (ICI).
    Ananthula, Aneesha
    Konda, Manojna
    Bimali, Milan
    Safar, Ahmad Mazen
    Govindarajan, Rangaswamy
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Predictive biomarkers for immune checkpoint inhibitors therapy in lung cancer
    Yao, Jie
    Lin, Xuwen
    Zhang, Xin
    Xie, Mei
    Ma, Xidong
    Bao, Xinyu
    Song, Jialin
    Liang, Yiran
    Wang, Qiqi
    Xue, Xinying
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [4] Tumour Burden as a Predictive Tool of Response to Immune Checkpoint Inhibitors (ICI) in Patients with Metastatic Non-Small-Cell Lung Cancer
    Icht, O.
    Domachevsky, L.
    Groshar, D.
    Dudnik, E.
    Rotem, O.
    Peled, N.
    Reinhorn, D.
    Jacobi, O.
    Shochat, T.
    Bernstine, H.
    Zer, A.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S531 - S532
  • [5] The incidence and predictive factors of hyperprogressive disease (HPD) in non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICI).
    Lee, Yeun Ho
    Kim, Hyeonseon
    Chung, Il-Young
    Song, Chiwoo
    Kim, Leeseul
    Choi, Horyun
    Kim, Jinah
    Oh, Youjin
    Lee, Grace Yujin
    Cho, Heayoon
    Chae, Young Kwang
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [6] Endocrine toxicity as an independent predictor of response to immune checkpoint inhibitors in lung cancer patients
    Charpidou, Andriani
    Panagiotou, Emmanouil
    Ntouraki, Sofia
    Vathiotis, Ioannis A.
    Livanou, Maria Effrosyni
    Trimis, Athanasios
    Syrigos, Konstantinos
    Peppa, Melpomeni
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [7] Clinical predictive factors in real world setting in advanced non-small cell lung cancer (NSCLC) patients (pts) treated with immune checkpoint inhibitors (ICI)
    Callejo, A.
    Marmolejo, D.
    Iranzo, P.
    Assaf, J. D.
    Pardo, N.
    Navarro, A.
    Martinez-Marti, A.
    Cedres, S.
    Diaz Mejia, N. M.
    Carbonell, C.
    Amat, R.
    Frigola, J.
    Felip, E.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S766 - S766
  • [8] Medication use among lung cancer patients before and after initiating immune checkpoint inhibitors: A population study.
    Mei, Chuchu
    Yang, Amy
    Shaver, Amy L.
    Nikita, Nikita
    Banks, Joshua
    Keith, Scott W.
    Lu-Yao, Grace L.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] Cardiotoxicity of Immune Checkpoint Inhibitors in Patients with Lung Cancer
    Chitturi, Kalyan R.
    Araujo-Gutierrez, Raquel
    McLean, Edward T.
    Xu, Jiaqiong
    Bhimaraj, Arvind
    Guha, Ashrith
    Hussain, Imad
    Trachtenberg, Barry H.
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S50 - S50
  • [10] Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer
    Huang, Yiqing
    Zhao, Joseph J.
    Soon, Yu Yang
    Kee, Adrian
    Tay, Sen Hee
    Aminkeng, Folefac
    Ang, Yvonne
    Wong, Alvin S. C.
    Bharwani, Lavina D.
    Goh, Boon Cher
    Soo, Ross A.
    CANCERS, 2023, 15 (10)
12345